Seminars in Liver Disease

Papers
(The H4-Index of Seminars in Liver Disease is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Expert Practical Recommendations for Hepatocellular Carcinoma103
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns40
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma37
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD33
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype27
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease26
Genetic and Epigenetic Basis of Drug-Induced Liver Injury26
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease25
HBV Biomarkers and Their Role in Guiding Treatment Decisions24
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis23
Towards Precision Medicine in MASLD: Evolution of Disease Subtyping23
MASH-Associated T Cell Activation and Neuroinflammation: Evidence for a Hepatosystemic Immune Axis20
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy20
Physiomimetic In Vitro Human Models for Viral Infection in the Liver19
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury19
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies17
0.88344478607178